NIH-funded research R01 grant

Preventing Growth Problems in Poor Children by Treating Small Intestine Bacteria

Official title: A Phase II Trial to Prevent Linear Growth Stunting and Malnutrition in Impoverished Children from a Low-Income Country by Treating Small Intestine Bacterial Overgrowth

Funded at University of Virginia · NIH-11478598 · Data updated 2026-11-12

A phase II effort in urban Bangladesh tests a treatment plan to stop growth failure and malnutrition in young children by addressing small intestinal bacterial overgrowth.

More Malnutrition research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startSeptember 16, 2025
Project endJune 30, 2030
Funding year2026
Award (this year)$210,341
NIH project number3R01HD113733-02S1
Project IDNIH-11478598 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children under 5 from high-SIBO prevalence communities, especially those with malnutrition or growth faltering.

Less likely to help

Children without SIBO or malnutrition, or those not meeting inclusion criteria, may not benefit from this intervention.

What this research studies

This project aims to find the best pediatric treatment for SIBO-related malnutrition in children, including those under 2 years, within a high-need setting. It will compare regimens that are practical in low-resource environments and seek to understand how the gut microbiome changes with treatment and how those changes relate to growth and metabolism. The study builds on observed high rates of SIBO among children with functional GI disorders and other conditions, and it focuses on improving growth and overall health. Outcomes will inform future care strategies for at-risk children in similar settings.

Why it matters

Potential benefit: If successful, the study could lead to clearer, more effective treatments for malnutrition linked to SIBO in young children, improving growth and health.

How similar studies have gone: Previous work shows SIBO is common in several pediatric GI conditions, but pediatric treatment comparisons in such settings are limited, making this study novel in its approach.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Donowitz, Jeffrey Ryan — University of Virginia
  • Study coordinator: Donowitz, Jeffrey Ryan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.